摘要
目的:分析复方苦参注射液联合参麦注射液治疗恶癌性胸腔积液的疗效。方法:选取2012年1月—2015年10月收治的恶癌性胸腔积液患者68例作为研究对象,按不同的治疗方法,将接受单纯顺铂胸腔灌注治疗的34例患者作为对照组,将接受复方苦参注射液联合参麦注射液治疗的34例患者作为观察组,治疗4周后,对两组治疗效果进行统计分析。结果:观察组总有效率为82.35%(28/34),对照组总有效率为76.47%(26/34),但差异无统计学意义(P>0.05);观察组不良反应发生率为20.59%(7/34),低于对照组44.12%(15/34),差异有统计学意义(P<0.05)。结论:对恶癌性胸腔积液患者的治疗,采取复方苦参注射液联合参麦注射液治疗的疗效显著,且不良反应少,值得临床推广使用。
Objective:To analyze the curative effect of compound Kushen injection and Shenmai injection in treating malignant pleural effusion.68cases of malignant pleural effusion patients treated from January2012to October2015were selected as research subjects and divided into the control group and the observation group according to the different treatment methods,34patients in the control group received pleural infusion of cisplatin alone while34patients in the observation group received compound Kushen injection and Shenmai injection.4weeks after treatment,the effect of two groups of treatment was statistically analyzed.Results:The total effective rate of the observation group was82.35%(28/34),and that of the control group was76.47%(26/34),but there was no statistically significant difference(P>0.05);the incidence of adverse reactions of the observation group was20.59%(7/34),which was significantly lower than that of the control group44.12%(15/34),the difference was statistically significant(P<0.05).Conclusion:Compound Kushen injection and Shenmai injection had significant effect in treating patients with malignant pleural effusion.It had less side effects and was worthy of clinical promotion.
出处
《中医临床研究》
2017年第3期111-112,共2页
Clinical Journal Of Chinese Medicine
基金
江苏中医肿瘤重点专科建设项目
项目编号:苏中医(2012)19号
编号42
2015年度南通市市级科技计划
项目编号:MS22015080
恶性淋巴瘤的中医诊疗规范
关键词
恶癌性胸腔积液
复方苦参注射液
参麦注射液
疗效
Malignant pleural effusion
Compound Kushen injection
Shenmai injection
Curative effect
